| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |